SAN DIEGO,
April 13, 2012 /PRNewswire/
-- Gen-Probe Incorporated (NASDAQ: GPRO) announced today that
the Company will release its first quarter 2012 financial results
on Thursday, May 3, 2012 at
approximately 4:00 pm Eastern Time
(ET). The announcement will be followed by a conference call with
management at 4:30 pm ET.
The conference call will be webcast live and may be
accessed on the investors section of the Company's web site at
www.gen-probe.com. An archived version of the webcast will be
available on the same web site for at least 90 days. A telephone
replay also will be available for 24 hours after the call ends. To
access the replay, please call 800-839-2338 (US) or 203-369-3673
(international).
About Gen-Probe
Gen-Probe is a global leader in the
development, manufacture and marketing of rapid, accurate and
cost-effective molecular diagnostic products and services that are
used primarily to diagnose human diseases, screen donated human
blood, and ensure transplant compatibility. Gen-Probe is
headquartered in San Diego and
employs approximately 1,400 people. For more information, go to
http://www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our
expectations, beliefs, plans, objectives, assumptions, or future
events or performance are not historical facts and are
forward-looking statements. Forward-looking statements are
not guarantees of performance. They involve known and unknown
risks, uncertainties and assumptions that may cause actual results
to differ materially from those expressed or implied. For
information about risks and uncertainties we face and a discussion
of our financial statements and footnotes, see documents we have
filed with the SEC, including our most recent Form 10-K, and all
subsequent periodic filings. We assume no obligation and
expressly disclaim any duty to update any forward-looking statement
to reflect events or circumstances after the date of this press
release or to reflect the occurrence of unanticipated
events.
SOURCE Gen-Probe Incorporated